Stay updated on Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now indicates the trial is no longer recruiting and adds user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment heading formatting is adjusted and the revision note updated from v3.5.5 to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-15T19:06:07.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    New revision history entries were added for 2026-06-01 and 2026-05-28 with Revision: v3.5.5, and older revision entries (2026-05-26, 2026-05-27) along with Revision: v3.5.4 were removed.
    Difference
    0.1%
    Check dated 2026-06-08T14:48:29.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Adds update-date entries (2026-05-27, 2026-05-26, 2026-05) and removes the Recruitment status and study contact details from the page, reducing visibility of current enrollment and direct contact options for potential participants.
    Difference
    4%
    Check dated 2026-06-01T05:19:59.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now shows the study as Active, not recruiting; it adds widened ILD/history exclusions and specifies contraception durations for R-Dx-d as 150 days during treatment and 210 days after the last dose.
    Difference
    0.6%
    Check dated 2026-05-18T03:48:48.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s page software revision label was updated from v3.5.2 to v3.5.3, indicating a minor platform/version maintenance change.
    Difference
    0.0%
    Check dated 2026-04-26T08:24:45.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Recruitment status updated to Completed on 2026-04-13. The revision was updated to v3.5.2, replacing the earlier v3.5.0 entry.
    Difference
    0.3%
    Check dated 2026-04-19T01:37:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page.